Rising Incidence of Heart Failure and Type 2 Diabetes Driving CKM Costs in Young Populations

Article Impact Level: HIGH
Data Quality: STRONG
Summary of  Circulation https://doi.org/10.1161/circ.152.suppl_3.4371025  
Dr. Tanuja Rajan  et al.

Points

Researchers utilized over forty billion insurance claims to quantify the rising economic burden of cardiovascular-kidney-metabolic syndrome in young adults from 2010 to 2019.
Total healthcare expenditures for this demographic increased by twenty-three percent during the study period to reach approximately eighteen billion dollars annually.
Heart failure treatment represented the most significant relative cost increase at one hundred twenty-two percent while type 2 diabetes remained the highest overall expense.
Emergency department services saw a forty-nine percent rise in spending which indicates a growing reliance on acute care for managing these chronic interconnected conditions.
The data revealed that Medicaid spending for these conditions surged by sixty-three percent which suggests a widening impact on vulnerable populations within the younger demographic.

Summary

This study analyzed trends in U.S. healthcare expenditures associated with cardiovascular-kidney-metabolic (CKM) syndrome among young adults between 2010 and 2019. CKM encompasses interconnected pathologies including heart disease, renal dysfunction, diabetes, and obesity, which increasingly manifest in early adulthood. Leveraging data from the Institute for Health Metrics and Evaluation (IHME) Disease Expenditure Project, researchers examined over 40 billion administrative claims and nearly 1 billion facility records to quantify spending across various payers and care settings.

Results indicate a significant economic burden, with total CKM-related spending for young adults rising by 23%, from approximately $14 billion to $18 billion over the decade. Among specific conditions, heart failure expenditures demonstrated the most substantial relative growth at 122%, followed by atrial fibrillation (48%), stroke (30%), and type 2 diabetes (23%). Conversely, spending for ischemic heart disease declined by 5%. Throughout the study period, type 2 diabetes consistently accounted for the largest proportion of total CKM expenditures, highlighting the central role of metabolic dysregulation in this syndrome.

Expenditure analysis by care type revealed the steepest increases in emergency department services (49%) and inpatient care (34%). Payer distribution in 2019 showed $10.4 billion attributed to private insurance and $4.6 billion to Medicaid, with the latter experiencing a 63% increase over the study period. Stratification by age demonstrated that young adults aged 30 to 34 years and 25 to 29 years faced the highest relative expenditure growth at 39% and 37%, respectively. These findings underscore the escalating clinical and economic impact of CKM syndrome on the younger demographic, necessitating targeted early intervention strategies.

Link to the article: https://www.ahajournals.org/doi/10.1161/circ.152.suppl_3.4371025

References

Rajan, T., Shahid, I., Javed, Z., Dong, W., Mossialos, E., & Al-Kindi, S. (2025). Abstract 4371025: Healthcare expenditure on cardiovascular-kidney-metabolic health in young adults aged 20 to 44 from 2010 to 2019. Circulation, 152(Suppl_3). https://doi.org/10.1161/circ.152.suppl_3.4371025